Eversheds advises Recordati Spa on the acquisition of shares in Opalia Pharma

Eversheds has advised Recordati Spa, an Italian group of pharmaceutical laboratories, on the acquisition of 67 per cent of shares in Tunisian pharmaceutical company Opalia Pharma.

Milan-based Recordati was advised by Eversheds Paris in collaboration with Eversheds El Heni in Tunisia, with partners Boris Martor, Farès Koussay El Heni, Raouf Mohamed El Heni and Dan Roskis working closely with associates Jawad Fassi-Fehri and Imène Boukadoum.

Further counsel was provided by Anna Buscall of Arnold & Porter.